Juliana Denekamp

Juliana Denekamp's AcademicInfluence.com Rankings

Juliana Denekamp

Biology

#6910

World Rank

#9727

Historical Rank

Biotechnology

#72

World Rank

#73

Historical Rank

biology Degrees

Download Badge

Biology

Juliana Denekamp's Degrees

Masters Biotechnology Stanford University

Why Is Juliana Denekamp Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Juliana Denekamp's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endothelial proliferation in tumours and normal tissues: continuous labelling studies. (1984) (569)
Late effects toxicity scoring: the SOMA scale (1995) (375)
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy (1993) (345)
A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. (1985) (318)
Endothelial cell proliferation as a novel approach to targeting tumour therapy. (1982) (264)
Changes in the rate of repopulation during multifraction irradiation of mouse skin. (1973) (245)
Endothelial-cell proliferation in experimental tumours. (1982) (229)
Vascular endothelium as the vulnerable element in tumours. (1984) (217)
Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. (1990) (209)
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts (1999) (208)
Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. (2002) (202)
Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. (2000) (197)
Cell kinetics and radiation biology. (1986) (180)
Vascular attack as a therapeutic strategy for cancer (1990) (178)
TUMOUR CELL PROLIFERATION IN RELATION TO THE VASCULATURE (1979) (157)
Radiosensitizers of hypoxic cells in solid tumors. (1976) (151)
Vascular occlusion and tumour cell death. (1983) (149)
Vinca alkaloids: anti-vascular effects in a murine tumour. (1993) (145)
Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. (2002) (136)
LATE EFFECTS TOXICITY SCORING : THE SOMA SCALE (1995) (128)
Survival of mouse skin epithelial cells following single and divided doses of x-rays. (1970) (118)
Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. (1975) (116)
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. (1995) (116)
Vasculature as a Target for Tumour Therapy (1984) (114)
Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. (1988) (113)
Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. (1974) (106)
Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. (1993) (106)
The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. (1986) (105)
Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. (1989) (102)
Skin reactions in mice after multifraction x-irradiation. (1974) (99)
Radiation-induced renal damage: the effects of hyperfractionation. (1984) (98)
Late radiation damage in the mouse bladder as measured by increased urination frequency. (1978) (97)
Late effects consensus conference: RTOG/EORTC. (1995) (94)
Changes in tumor hypoxia measured with a double hypoxic marker technique. (2000) (92)
The therapeutic advantage of combined heat and X rays on a mouse fibrosarcoma. (1978) (90)
The cellular proliferation kinetics of animal tumors. (1970) (90)
Inducible repair and the two forms of tumour hypoxia--time for a paradigm shift. (1999) (83)
Recovery and repopulation in mouse skin as a function of time after x-irradiation. (1969) (82)
The response of six mouse tumours to combined heat and X rays: implications for therapy. (1979) (81)
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933. (1999) (80)
Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours. (1972) (79)
PROLIFERATION STUDIES OF THE ENDOTHELIAL AND SMOOTH MUSCLE CELLS OF THE MOUSE MESENTERY AFTER IRRADIATION (1980) (79)
The relationship between the 'cell loss factor' and the immediate response to radiation in animal tumours. (1972) (73)
The effect of vascular occlusion on the thermal sensitization of a mouse tumour. (1978) (72)
Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas (1982) (71)
Sequential functional testing of radiation-induced renal damage in the mouse. (1983) (69)
Brachial Plexopathy After Postoperative Radiotherapy of Breast Cancer Patients: A Long-Term Follow-up (2000) (68)
RBE values and repair characteristics for colo-rectal injury after caesium 137 gamma-ray and neutron irradiation. II. Fractionation up to ten doses. (1984) (67)
IN VITRO AND IN VIVO LABELLING OF ANIMAL TUMOURS WITH TRITIATED THYMIDINE (1973) (67)
Residual radiation damage in mouse skin 5 to 8 months after irradiation. (1975) (67)
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. (1995) (67)
Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro. (1984) (66)
A review of hypoxic cell radiosensitization in experimental tumors. (1979) (66)
Recovery and repopulation in mouse skin after irradiation with cyclotron neutrons as compared with 250-Kv x-rays or 15-Mev electrons. (1966) (66)
Is tumour radiosensitization by misonidazole a general phenomenon? (1980) (65)
Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia. (1982) (65)
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. (1976) (64)
The response of mesenteric blood vessels to irradiation. (1979) (58)
New insights into factors influencing the clinically relevant oxygen enhancement ratio. (1998) (58)
Sensitization of mouse skin to X irradiation by moderate heating. (1977) (58)
Thiol radioprotection in vivo: the critical role of tissue oxygen concentration. (1981) (56)
CHANGES IN THE PROLIFERATION RATE OF MOUSE EPIDERMIS AFTER IRRADIATION: CONTINUOUS LABELLING STUDIES (1976) (56)
Radioprotection of mouse skin by WR-2721: the critical influence of oxygen tension. (1982) (55)
Radiotherapy employing three fractions on each of twelve consecutive days. (1988) (55)
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC). (2000) (55)
Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? (1998) (54)
Further investigations of the response of irradiated mouse skin. (1966) (54)
Radiation induced renal damage in mice: influence of fraction size. (1984) (54)
Predicting realistic RBE values for clinically relevant radiotherapy schedules. (1997) (54)
In vivo assessment of basic 2-nitroimidazole radiosensitizers. (1982) (53)
Tumour regression as a guide to prognosis: a study with experimental animals. (1977) (53)
The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses. (1983) (52)
The proportion of hypoxic cells in a human tumor. (1977) (52)
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. (1978) (51)
Biphasic survival curves for XRS radiosensitive cells: subpopulations or transient expression of repair competence? (1989) (49)
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC. (1999) (48)
Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatments. (1983) (47)
Angiogenic attack as a therapeutic strategy for cancer. (1991) (46)
The effect of pentobarbital anaesthesia on the radiosensitivity of four mouse tumours. (1979) (46)
The cell proliferation kinetics of four experimental tumors after acute X-irradiation. (1971) (44)
Changes in the Rate of Proliferation in Normal Tissues After Irradiation1 (1975) (44)
Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. (1974) (43)
Cell kinetics and cancer therapy (1982) (42)
Cell Proliferation Kinetics and Radiation Therapy (1977) (42)
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study. (1997) (40)
Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents. (1984) (40)
Preferential sensitization of hypoxic cells to radiation in vivo. (1972) (40)
The current status of targeting tumour vasculature as a means of cancer therapy: an overview. (1991) (40)
Misonidazole in fractionated radiotherapy: are many small fractions best? (1980) (40)
Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. (1995) (40)
The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582. (1976) (38)
The effects of melphalan and misonidazole on the vasculature of a murine sarcoma. (1987) (38)
Reduced thermal sensitivity of the vasculature in a slowly growing tumour. (1989) (38)
Response of human tumour xenografts to fractionated X-irradiation. (1986) (37)
Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON). (1994) (37)
Correction for the use of the SOMA LENT tables. (1996) (37)
Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy. (1992) (36)
RBE values for colo-rectal injury after caesium 137 gamma-ray and neutron irradiation. I. Single doses. (1983) (36)
ARCON--current status: summary of a workshop on preclinical and clinical studies. (1997) (35)
Fractionation studies with WR-2721: normal tissues and tumour. (1986) (35)
The interaction between X-rays and 3 MeV neutrons in the skin of the mouse foot. (1984) (35)
Increased collagen and fluid content of mouse kidneys at 9 months after single or fractionated X irradiation. (1984) (35)
Modification of the radiation response of the mouse kidney by misonidazole and WR-2721. (1983) (34)
Evidence for repair capacity in mouse tumors relative to skin. (1979) (34)
Tumour stem cells: facts, interpretation and consequences. (1994) (34)
Theoretical simulation of oxygen tension measurement in tissues using a microelectrode: I. The response function of the electrode. (2001) (34)
Low radioprotection by thiol in lung: the role of local tissue oxygenation. (1983) (33)
Fractionation studies with combined X rays and hyperthermia in vivo. (1980) (32)
The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation. (1982) (32)
The response of mouse skin to fractionated x rays. (1975) (31)
Neutron RBEs for mouse skin at low doses per fraction. (1984) (31)
Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation. (1993) (30)
Does local tumour heating im mice influence metastatic spread? (1982) (30)
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. (1998) (30)
The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. (1985) (30)
Site dependent response of tumours to combined heat and radiation. (1982) (30)
Repair during fractionated irradiation of the mouse bladder. (1981) (29)
Studies of the processes occurring between two fractions in experimental mouse tumors. (1976) (29)
Inadequate vasculature in solid tumours: consequences for cancer research strategies. (1992) (28)
Response of mouse epidermal cells to single and divided doses of fast neutrons. (1971) (27)
Radiosensitization of solid tumors by nitroimidazoles. (1978) (26)
Enhancement of misonidazole radiosensitization by buthionine sulphoximine. (1984) (26)
Cytotoxicity and radiosensitization in mouse and man. (1978) (26)
Inducible Repair and Intrinsic Radiosensitivity: A Complex but Predictable Relationship? (2000) (26)
Pions and pig skin: preclinical evaluation of RBE for early and late damage. (1986) (26)
Early and late radiation reactions in mouse feet. (1977) (26)
Superfractionation as a potential hypoxic cell radiosensitizer: prediction of an optimum dose per fraction. (1999) (26)
Radiation induced renal damage in mice: influence of overall treatment time. (1984) (25)
Evidence for a constant repair capacity over 20 fractions of X-rays. (1986) (25)
The choice of experimental models in cancer research: The key to ultimate success or failure? (1992) (24)
Theoretical simulation of oxygen tension measurement in the tissue using a microelectrode: II. Simulated measurements in tissues. (2002) (24)
Precipitation of latent renal radiation injury by unilateral nephrectomy. (1986) (24)
Stromal damage as a complication in the interpretation of tumour growth delay. (1983) (24)
Selective induction of endothelial cell tissue factor in the presence of a tumour‐derived mediator: A potential mechanism of flavone acetic acid action in tumour vasculature (1991) (24)
Brachial plexopathy after postoperative radiotherapy of breast cancer patients--a long-term follow-up. (1999) (23)
Regulation of Epidermal Stem Cells (1976) (23)
The RBE for renal damage after irradiation with 3 MeV neutrons. (1984) (22)
Sensitization of mouse tumours using fractionated X-irradiation. (1978) (22)
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules. (1996) (22)
Factors influencing the chemosensitization of melphalan by misonidazole. (1985) (22)
Differences in chemosensitivity between subcutaneous and pulmonary tumours. (1985) (22)
The response of a transplantable tumor to fractionated irradiation. II. Fast neutrons. (1976) (22)
Experimental radiotherapy with WR-2721 and misonidazole. (1982) (20)
Is the outlook grey for WR-2721 as a clinical radioprotector? (1983) (20)
Early detection of damage following bilateral renal irradiation in the mouse. (1991) (19)
The effect of small radiation doses on mouse skin. (1986) (19)
Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions. (1987) (19)
The influence of X ray dose levels on normal tissue radioprotection by WR-2721. (1984) (19)
The Response of a Mouse Sarcoma to Single and Divided Doses of X-rays and Fast Neutrons (1974) (19)
Histology as a method for determining thermal gradients in heated tumours. (1982) (19)
[Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale]. (1997) (19)
Experimental tumor systems: standardization of endpoints. (1979) (19)
Left sided vocal cord paralysis: a newly recognized late complication of mediastinal irradiation. (2001) (18)
Studies with a panel of tumours having a variable sensitivity to FAA, to investigate its mechanism of action. (1991) (18)
Early and late effects in mouse lung and rectum. (1982) (17)
Is any single in situ assay of tumour response adequate? (1980) (17)
Radiation Effects on Normal Tissues (1977) (17)
Correction for the use of the SOMA LENT tables. American and European LENT Working Committees. (1996) (16)
The influence of overall treatment time on renal injury after multifraction irradiation. (1985) (16)
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization. (1983) (16)
Hyperfractionation as an effective way of overcoming radioresistance. (1998) (16)
Hypoxic cell sensitlzation by misonidazole in vivo and in vitro (1978) (15)
Repair factors for multifraction irradiations. (1984) (15)
The response of mouse epidermis to fractionated doses of pi mesons. (1987) (15)
Biological Basis of Radiosensitization by Hypoxic-Cell Radiosensitizers (1976) (15)
In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration. (1982) (15)
The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours. (1978) (14)
Hypoxic cell sensitizers: early or late in fractionated therapy? (1978) (14)
Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection. (1982) (14)
Testing of hypoxic cell radiosensitizers in vivo. (1980) (14)
Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration. (1983) (14)
Redox competition and radiosensitivity: implications for testing radioprotective compounds. (1988) (13)
The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582. (1977) (13)
Fractionation up to ten doses (1984) (13)
Cell kinetics and radiation pathology (1989) (12)
The fractionated response of mouse stroma after X-rays and neutrons: influence of early vs late expression of damage. (1989) (12)
The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro. (1999) (12)
Joint statement of mission by the RTOG/EORTC working groups (1995) (12)
Factors influencing the estimates of proliferative labelling indices in rectal cancer. (1998) (11)
The effect of vinca alkaloids on tumour blood flow. (1994) (11)
Glutathione and misonidazole: independent or interactive mechanisms of action? (1985) (11)
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies. (1993) (11)
RBE values for regrowth of C3H mouse mammary carcinomas after single doses of cyclotron neutrons or X-rays. (1973) (11)
Radioprotection in Vivo: Cellular Heterogeneity and Fractionation (1987) (11)
Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys. (1996) (11)
Hypoxia, normoxia and hyperoxia--terminology for medical in vitro cell biology. (2000) (10)
Swedish Cancer Society radiation therapy research investigation. (2002) (10)
Effects of radiomodifiers on high and low LET responses in vivo. (1984) (9)
Actinomycin D and radiation: effects on mouse lung. (1986) (9)
Neutron radiobiology revisited. (1994) (9)
Lung radioprotection by WR-2721 at low X-ray doses per fraction. (1984) (9)
Chemosensitization of mouse tumors by misonidazole. (1982) (9)
Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neck. (1988) (8)
A comparison of vascular-mediated tumor cell death by the necrotizing agents GR63178 and flavone acetic acid. (1992) (8)
Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour. (1993) (8)
Limited role of vasculature-mediated injury in tumor response to radiotherapy. (1993) (8)
Hypoxic cell sensitization by misonidazole in vivo and in vitro. (1978) (8)
Time-dependent recovery in the kidney. (1986) (8)
Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo. (1982) (8)
Repair rates: from basic studies to the clinic. (1989) (7)
113Late effects of normal tissues (LENT) scoring system: The SOMA scale (1996) (7)
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation. (1999) (7)
ON THE CONDENSATION OF AN INJECTED VAPOR BUBBLE IN A SUBCOOLED LIQUID STREAM (1972) (7)
Repair and repopulation in mouse skin during fractionated neutron and x-irradiation. (1974) (7)
Gamma contamination of neutron beams. (1980) (6)
The CellularProliferation Kinetics of Animal rs (1970) (6)
Stromal sensitivity to radiation and hyperthermia. (1987) (6)
Swedish Cancer Society Radiation Therapy Research Investigation (2002) (6)
Radiosensitization of mouse skin by oxygen and depletion of glutathione. (1995) (6)
Tumor sensitization and protection: influence of stromal injury on estimates of dose modification. (1984) (6)
The effect of fractionated doses of neutrons on C3H mouse mammary tumours. (1974) (6)
Loss of therapeutic advantage for combined heat and X-rays with fractionation (1982) (6)
Hyperthermia treatment of experimental tumors. (1981) (6)
Blood samples from mice: the influence of sampling site. (1982) (6)
The broad spectrum of preclinical radiobiology: British contributions. (1996) (6)
Cell proliferation kinetics in rodent tumours (1968) (5)
Radiation Science of Molecules, Mice and Men (1992) (5)
The therapeutic advantage of combined X-rays and melphalan. (1984) (5)
Therapeutic benefit from combined heat and radiation. (1988) (5)
Normal Tissue Response to Radiation: Experimental (1988) (5)
Labelling indices in human tumours: to apply corrections or not – that is the question (1999) (5)
Modifiers of radiosensitivity (1989) (4)
In Vitro and in Vivo Studies of the TRIUMF Pion Therapy Beam (1985) (4)
The impact of tissue microenvironment on treatment simulation. (2003) (4)
Radioprotection of normal tissues of the mouse by hypoxic breathing. (1989) (4)
An experimental study of tumour size and radiosensitivity: analysis by regrowth delay. (1989) (4)
The influence of pre-treatment temperature on the thermal sensitivity of a mouse tumour. (1985) (4)
The change in the rate of repopulation during multifraction irradiation of mouse skin. (1972) (2)
Biological Methods for Studying Radiosensitization (1982) (2)
Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation? (2004) (2)
Cell proliferation kinetics of tumours in relation to cancer therapy. (1989) (2)
Proceedings: Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. (1974) (2)
Proceedings: Fractionation studies on tumours using X rays and fast neutrons and the modification by electron affinic sensitizers. (1975) (2)
Time dependence of interaction of misonidazole and WR-2721. (1983) (2)
Anti-vascular cancer therapy: is it a dream or reality? (1991) (2)
Re-oxygenation of tumours after irradiation and cell population kinetics. (1969) (2)
Comments on `Standard effective doses for proliferative tumours' (2000) (2)
The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours. (1996) (2)
Preclinical evaluation of pions in vivo: experience at TRIUMF. (1990) (2)
Computer simulation of oxygen microelectrode measurements in tissues. (2003) (2)
Entering the third millennium after a century of ionizing radiation in science and oncology. (1999) (2)
Radiation effects on man and animals. (1989) (2)
Patterns of recovery and repopulation in irradiated skin (1973) (1)
[Angiogenesis--a new field for cancer therapy]. (1991) (1)
Effect of glutathione depletion on radiosensitivity in vivo (1984) (1)
New Approaches to the Measurement of Proliferation Rates (1992) (1)
Tumour regression and radiation response. Abstr. (1977) (0)
Functional and proliferative characteristics of neovasculature as potential targets in tumour therapy (1997) (0)
Proceedings: Tests of hypoxic cell sensitizers using epidermal cell survival in vivo. (1975) (0)
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for glioblastoma: Results of EORTC 22933 (1998) (0)
Terminology for Medical In Vitro Cell Biology (2000) (0)
In vitro and in vivo studies of the TRIUMF pion therapy beam. (1985) (0)
Combined radiotherapy and radioimmotherapy of human colon carcinoma grafted in nude mice. (1995) (0)
Vascular Proliferation in Tumours and its Influence on Cancer Therapy (1992) (0)
In Vivo Testing of Radiosensitizers (1982) (0)
Cell population kinetics in four rodent tumours. Abstr. (1968) (0)
An experimental study of tumour size and analysis by regrowth delay (1989) (0)
Book reviewGrowth Kinetics of Tumours (Cell population kinetics in relation to the growth and treatment of cancer). By SteelG. G., pp. xi + 351, illus., 1977 (Oxford, Clarendon Press) £15·00. (1978) (0)
Anti-Angiogenic Versus Anti-Vascular Approaches to Cancer Therapy (1992) (0)
New approaches to overcome radiobiological hypoxia: Experimental experience (1993) (0)
The links between hypoxia, DNA repair, ATP and radiosensitivity: time for a paradigm shift (1999) (0)
ANNOUNCEMENTS (1976) (0)
Tumour growth and cancer therapy. (1980) (0)
The effect of BW12C on the radiosensitivity and necrosis of murine tissues and tumours. (1994) (0)

This paper list is powered by the following services:

Juliana Denekamp's Academic­Influence.com Rankings

Juliana Denekamp's Degrees

Why Is Juliana Denekamp Influential?

Juliana Denekamp's Published Works

Published Works

Juliana Denekamp's AcademicInfluence.com Rankings